| Ankur Drugs & Pharma has reported a sales turnover of Rs 150.19 crore and a net loss of Rs 20.09 crore for the quarter ended Dec '10. | | For the quarter ended Dec 2009 the sales turnover was Rs 260.40 crore and net profit was Rs 28.14 crore. |
|
| | Quarterly Results of Ankur Drugs & Pharma | -------- in Rs. Cr. -------- |
|
| Dec '09 | | | Sep '10 | Dec '10 | | Sales Turnover | 260.40 | | | 272.75 | 150.19 | | Other Income | 0.43 | | | 0.19 | 0.22 | | Total Income | 260.83 | | | 272.93 | 150.40 | | Total Expenses | 206.01 | | | 212.88 | 128.47 | | Operating Profit | 54.39 | | | 59.87 | 21.72 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | 0.58 | | | -- | -2.27 | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 54.82 | | | 60.06 | 21.94 | | Interest | 12.46 | | | 27.90 | 25.23 | | PBDT | 42.95 | | | 32.16 | -5.57 | | Depreciation | 5.99 | | | 9.91 | 19.25 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 36.96 | | | 22.25 | -24.82 | | Tax | 8.82 | | | 4.40 | -4.73 | | Net Profit | 28.14 | | | 17.85 | -20.09 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 14.55 | | | 9.23 | -- | | Book Value | -- | | | -- | -- | | Equity | 19.34 | | | 19.34 | 19.34 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
